A best evidence topic was constructed according to a structured protocol. The question addressed was whether the use of transcutaneous electrical nerve stimulation (TENS) is effective in reducing post-thoracotomy pain. Of the 74 papers found with a report search, nine prospective randomized controlled trials (RCT), among which three were double-blind, presented the best evidence to answer the clinical question. All investigated the effect of TENS as an adjunct therapy for relieving acute post-thoracotomy pain in patients undergoing thoracic surgery. The authors, journal, date and country of publication, study type, group studied, relevant outcomes and results of these papers are given. We conclude that a vast majority -seven of the nine retrieved studies -were in favor of TENS as an adjuvant to narcotic analgesics for improving outcome after thoracic surgery. Indeed, the interest and benefit has been shown not only in the treatment of acute post-thoracotomy pain (pain scores and narcotic requirements were consistently lower in the TENS group as opposed to the Placebo-TENS group), but also when used together with narcotic analgesics to reduce the duration of recovery room stay and to increase chest physical tolerance (better coughing attempts during chest physiotherapy) with positive effects on pulmonary ventilator function wforced expiratory volume in 1 s (FEV ) andyor forced vital capacity (FVC)x. Specifically, the TENS treatment was shown to be ineffective when 1 used alone in severe post-thoracotomy pain (i.e. posterolateral thoracotomy incision), but useful as an adjunct to other medications in moderate post-thoracotomy pain (i.e. muscle sparing thoracotomy incision) and very effective as the sole pain-control treatment in patients experiencing mild post-thoracotomy pain (i.e. video-assisted thoracoscopy incision). Hence, current evidence shows TENS associated with postoperative medications to be safe and effective in alleviating postoperative pain and in improving patient recovery, thus enhancing the choice of available medical care and bettering outcome after thoracic surgery.
Introduction
A best evidence topic was constructed according to a structured protocol described in the ICVTS w1x.
Three-part question
In wpatients undergoing thoracotomy for lung surgeryx is wtranscutaneous electrical nerve stimulation associated with analgesic treatmentx superior to wanalgesic treatment alonex in wreducing postoperative painx?
Clinical scenario
At day 1 after a left upper lobectomy -done via posterolateral thoracotomy incision -you see a 65-year-old patient for whom postoperative pain cannot be controlled with the usual narcotics. The patient's pain report on the numeric *Corresponding author. Department of Thoracic Surgery, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, 1 place de l 'Hôpital, BP 426, 67091 Strasbourg Cedex, France. Tel.: q33-3-69551134 ; fax: q33-3-69551895.
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rating scale is 6 at rest and 8 when coughing. The patient has a smoking history of 40 cigarettes a day for 30 years and a chronic obstructive pulmonary disease, both of which justify adequate chest physical therapy. The narcotics used are associated with undesirable side effects (nausea and vomiting). You wonder if transcutaneous electrical nerve stimulation (TENS) might be a relevant adjuvant to narcotics in controlling acute postoperative pain. You propose this therapeutic option to the patient, who argues that it would probably make things worse. You, therefore, decide to look up the evidence in the literature.
Search strategy
Medline 1980-May 2009, using the OVID interface, with results limited to human subjects and English language articles: wthoracic surgeryx AND wtranscutaneous electrical nerve stimulationx. The centre for evidence-based physiotherapy (CEBP), developed to give rapid access to bibliographic details and abstracts of randomized controlled trials (RCT), systematic reviews and evidence-based clinical practice guidelines in physiotherapy; http:yywww.pedro. fhs.usyd.edu.auyindex.html, was also searched. Finally, a hand search was used to follow-up references from the retrieved studies.
Search outcome
Nine papers were selected from a total of 74 abstracts (including 3 non-systematic reviews) retrieved to providing the best evidence on the topic. These papers are documented in Table 1 .
Results
Nine prospective RCT were identified. Miller-Jones et al. w2x designed a prospective RCT to investigate the effectiveness of TENS in relieving post-thoracotomy pain. Twenty-eight patients were included: 14 in the TENS group and 14 in the No-TENS group. The results showed that: there was no significant difference in the mean value of forced expiratory volume in 1 s (FEV ) 1 between those who had TENS and those who did not; the amount of opiates used was lower in the TENS group than in the No-TENS group (P)0.05); the No-TENS group had a lower pain score (P)0.05).
Stratton and Smith w3x performed a prospective RCT to measure the effects of TENS on patients who had undergone thoracotomies. Twenty-one patients were assigned either to the TENS group (ns11) or the No-TENS group (control group, ns10). The data indicated a statistically significant increase in forced vital capacity (FVC) during stimulation (P-0.01), suggesting that TENS during application improves chest expansion and mobility in patients.
Rooney et al. w4x conducted a prospective randomized double-blind study to evaluate the efficacy of TENS in relief of post-thoracotomy pain by comparing postoperative narcotic requirements in 22 patients having TENS and in 22 patients having sham electrical stimulation (Placebo-TENS group). When TENS was used, 22.7% of the patients required no narcotics in the first 24 postoperative hours (P-0.05). All patients having sham stimulation required postoperative narcotics.
Warfield et al. w5x performed a prospective randomized double-blind study to assess the effect of TENS on pain after thoracotomy for pulmonary resection. Twenty-four patients were randomly assigned to an experimental group (TENS group, ns12) or a control group treated with sham stimulator setups (Placebo-TENS group, ns12). Patients in the TENS group had lower pain scores during the first 24 postoperative hours (Ps0.014), shorter recovery room stay (Ps0.013), and better tolerance of chest physical therapy on both day 1 (Ps0.018) and day 2 (Ps0.0064).
Liu et al. w6x designed a prospective RCT to examine the effect of TENS on 30 patients who had undergone thoracotomy. Patients were randomly allocated to either an experimental group (group 1: TENS at the most comfortable intensity of current, ns15) or a control group (group 2: TENS at the lowest intensity of current, ns15). The results showed that TENS had alleviated postoperative pain significantly in group 1. The range of motion (ROM) of shoulder flexion had increased and functional activity had improved. The length between operation and discharge showed no significant difference between the two groups.
Stubbing and Jellicoe w7x performed a prospective RCT to assess the effect of TENS following thoracotomy on 40 patients scheduled to thoracic surgery. Forty patients were randomly assigned to the TENS group (ns20) or the No-TENS (ns20). The use of TENS did not significantly alter the requirements for analgesia although there was a reduction in postoperative nausea and vomiting in the TENS group (Ps0.04). There was no difference between the two groups with respect to changes in peak expiratory flow rate (PEFR).
Benedetti et al. w8x designed a prospective RCT to investigate the effect of TENS on postoperative pain in 324 patients having undergone different types of thoracic surgical procedures. The TENS treatment was not effective in posterolateral thoracotomy (severe pain), but was useful as an adjunct to other medications in the muscle-sparing thoracotomy, costotomy, and sternotomy groups (moderate pain). In contrast, it was very effective as the sole pain control treatment in patients having video-assisted thoracoscopy (mild pain).
Erdogan et al. w9x performed a prospective randomized placebo-controlled study of the effect of TENS on postthoracotomy pain and pulmonary function. One hundred and sixteen patients were randomly assigned to the TENS group (ns60) or a control group (Placebo-TENS, ns56) . The use of TENS reduced the need to administer opioids during the 5-day postoperative period (Ps0.013). TENS increased the spirometric respiratory function and the arterial blood gases.
Solak et al. w10x examined the effect of TENS on postthoracotomy pain and pulmonary function of 40 patients scheduled to undergo posterolateral thoracotomy with a prospective RCT. Patients were randomly allocated to either an experimental group (group 1: TENS, ns20) or a patientcontrolled analgesia (PCA) group (group 2: No-TENS, ns20). TENS provided better pain relief and comfort compared to PCA from the fourth postoperative day onwards, and this pain-reducing effect continued for at least two months postoperatively.
Clinical bottom line
On the whole, seven of the nine studies presented were clearly in favor of TENS as an adjuvant to narcotic analgesics for improving outcome after thoracic surgery. Indeed, the interest and benefit was shown not only in the treatment of acute post-thoracotomy pain, but also when used together with narcotic analgesics, in reducing the duration of recovery-room stay, increasing chest physical tolerance with positive effects on pulmonary ventilator function. Hence, current evidence shows TENS associated with postoperative medications to be safe and effective in alleviating postoperative pain and in improving patient recovery after thoracic surgery.
